Thema
Journal Article
56
Research Support, Non-U.S. Gov't
28
Antibodies, Neutralizing
16
Antibodies, Viral
16
Antibodies, Monoclonal
15
SARS-CoV-2
11
Spike Glycoprotein, Coronavirus
11
spike protein, SARS-CoV-2
10
Epitopes
7
neutralization
7
Angiotensin-Converting Enzyme 2
6
EC 3.4.17.23
6
Meta-analysis
6
Nanopore
6
Polymorphism
6
antibody
6
variant
6
COVID-19 Vaccines
5
ACE2 protein, human
4
COVID-19
4
Dwell time
4
Nanofiber mesh
4
Research Support, N.I.H., Extramural
4
Salt concentration gradient
4
escape
4
570
3
615
3
B82Y: Specific uses or applications of nanostructures; measurement or analysis of nanostructures; manufacture or treatment of nanostructures
3
Biology
3
EC 3.4.15.1
3
Hepatocellular carcinoma
3
Mannose-binding lectin
3
Omicron
3
Peptidyl-Dipeptidase A
3
Published Erratum
3
Pulmonary tuberculosis
3
RBD
3
Receptors, Virus
3
Susceptibility
3
Volksrepublik China
3
gene
3
phy
3
spike
3
structure
3
vaccine
3
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
2
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
2
Antigen-Antibody Complex
2
Bacterial Proteins
2
C07D: Heterocyclic compounds (macromolecular compounds c08)
2
mehr ...